Cargando…
Community-acquired pneumonia
Community-acquired pneumonia causes great mortality and morbidity and high costs worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of patients with pneumonia. To reduce the misuse of antibiotics, antibiotic resistance, and side-effects, an empirical, effective,...
Autores principales: | Prina, Elena, Ranzani, Otavio T, Torres, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173092/ https://www.ncbi.nlm.nih.gov/pubmed/26277247 http://dx.doi.org/10.1016/S0140-6736(15)60733-4 |
Ejemplares similares
-
Nosocomial pneumonia in the intensive care unit: how should treatment
failure be predicted?
por: Ranzani, Otavio T., et al.
Publicado: (2014) -
Biomarkers in community-acquired pneumonia: can we do better by using them correctly?
por: Ranzani, Otavio Tavares, et al.
Publicado: (2019) -
Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018) -
Ventilator-associated pneumonia
por: Ranzani, Otavio T., et al.
Publicado: (2022) -
Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia
por: Ranzani, Otavio T., et al.
Publicado: (2019)